Poornima Ajay Manjrekar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Poornima Ajay Manjrekar has a total of 77 co-authors. Here are the top co-authors by number of shared publications:
Anupama Hegde
Kasturba Medical College Mangalore
5 shared publications- Chakrapani Mahabala
Department of General Medicine, Kasturba Medical College, Mangalore, Manipal Academy of Higher Education, Manipal, Karnataka, India
5 shared publications - Rukmini Mysore Srikantiah
Department of Biochemistry, Kasturba Medical College Mangalore, Manipal Academy of Higher Education, Manipal, India
5 shared publications - Senna Mukhi
Department of Biochemistry, Kasturba Medical College, Mangalore, Manipal Academy of Higher Education, Manipal
4 shared publications - Sindhu Harish
Department of Biochemistry, Kasturba Medical College Mangalore, Manipal Academy of Higher Education, Manipal, India
4 shared publications Deenadhayalan Ashok
Kasturba Medical College Mangalore
3 shared publications
Latest Publications
- Open Access
- 1 October 2026
- Published by Wiley in Journal of Diabetes Investigation
Renal glycogen handling in diabetes: A narrative review of diabetic kidney disease pathogenesis
Kidney disease is a major microvascular complication of diabetes, affecting approximately 40% of individuals with diabetes, and is a leading cause of end‐stage renal disease. Besides the functional consequences of hyperglycemia; hemodynamic alterations are well understood. Activation of the sorbitol and hexosamine pathways, formation of advanced glycated products, and prevailing oxidative stress in the background of diabetic hyperglycemia are determinants of diabetic kidney disease (DKD) and its progression. The contribution of ectopic glycogen deposition remains unexplored. Glycogen metabolism in the kidneys is well regulated under physiological conditions, yet chronic hyperglycemia disrupts this balance across podocytes, tubular cells, and the glomerulus. Abnormal glycogen buildup has been observed in experimental diabetes models and human biopsy samples. GSK3β inactivation and mTORC1 upregulation emerge as central regulators. Metformin and SGLT2 inhibitors alter renal glycogen flow via AMPK‐dependent pathways, a potential avenue for therapeutic exploration. The significance of observational studies needs to be further explored for the potential involvement of glycogen buildup in the pathogenesis of DKD. This narrative review aims to provide a comprehensive understanding of glycogen metabolism, examine the dysregulation of key enzymes and signaling pathways, collate available evidence from animal and clinical studies and propose hypothesis that glycogen accumulation may have an additive role in the progression of DKD.
- 1 October 2026
- Published by Wiley in Journal of Diabetes Investigation
Open AccessRenal glycogen handling in diabetes: A narrative review of diabetic kidney disease pathogenesis
Kidney disease is a major microvascular complication of diabetes, affecting approximately 40% of individuals with diabetes, and is a leading cause of end‐stage renal disease. Besides the functional consequences of hyperglycemia; hemodynamic alterations are well understood. Activation of the sorbitol and hexosamine pathways, formation of advanced glycated products, and prevailing oxidative stress in the background of diabetic hyperglycemia are determinants of diabetic kidney disease (DKD) and its progression. The contribution of ectopic glycogen deposition remains unexplored. Glycogen metabolism in the kidneys is well regulated under physiological conditions, yet chronic hyperglycemia disrupts this balance across podocytes, tubular cells, and the glomerulus. Abnormal glycogen buildup has been observed in experimental diabetes models and human biopsy samples. GSK3β inactivation and mTORC1 upregulation emerge as central regulators. Metformin and SGLT2 inhibitors alter renal glycogen flow via AMPK‐dependent pathways, a potential avenue for therapeutic exploration. The significance of observational studies needs to be further explored for the potential involvement of glycogen buildup in the pathogenesis of DKD. This narrative review aims to provide a comprehensive understanding of glycogen metabolism, examine the dysregulation of key enzymes and signaling pathways, collate available evidence from animal and clinical studies and propose hypothesis that glycogen accumulation may have an additive role in the progression of DKD.
- Open Access
- 16 March 2026
- Published by Elsevier in Applied Food Research
- Vol. 6 (1)
Assessment of heavy metal leaching from packaging materials into fruit juices: Perspective from Southern India
- 16 March 2026
- Published by Elsevier in Applied Food Research
- Vol. 6 (1)
Open AccessAssessment of heavy metal leaching from packaging materials into fruit juices: Perspective from Southern India
- Open Access
Operational merit of Controlled Attenuation Parameter and Liver Stiffness Measurement across grades of Metabolic Dysfunctional Associated Steatotic Liver Disease: A cross-sectional study
Aim and objectives: Metabolic dysfunction-associated steatotic liver disease (MASLD) contributes significantly to global NCD mortality. Often asymptomatic until advanced; early diagnosis prevents worsening. Given the limitations of liver biopsy, non-invasive tests (NITs) like Controlled Attenuation Parameter(CAP) and Liver Stiffness Measurement(LSM) offer promising alternatives. The present study aimed to correlate CAP with LSM and assess CAP and LSM accuracy for stratifying early steatosis and fibrosis using vibration-controlled transient elastography (VCTE). Methods: The SmartExam ® equipment was used in patients at risk for or diagnosed with MASLD. This cross-sectional, prospective, tertiary care hospital-based study included 128 adult patients undergoing ultrasonography and/ or fibro-scan. Results: Participants with steatosis grades 0-3 showed a significant increase in CAP and LSM with disease grades. A strong positive correlation existed between CAP and LSM (r=0.785, p<0.001), highlighting the interdependence of steatosis and liver stiffness. CAP demonstrated excellent diagnostic accuracy for hepatic steatosis (AUROC 1.000, p<0.001), showing substantial increases with steatosis progression. The sensitivity and specificity among individuals with high BMI/WHR were found to be 90.63% and 100% respectively, with a diagnostic accuracy of 97.66%. LSM showed marked elevation for advanced fibrosis, and the performance characteristics were found to be 81.25% sensitive, 82.29% specific, with a diagnostic accuracy of 82.03% in the higher BMI/WHR groups. Conclusion: Our study confirms CAP’s excellent performance in diagnosing and stratifying hepatic steatosis and LSM’s potential role in assessing fibrosis, including early stages of MASLD. The strong CAP-LSM correlation promises synergistic utility across all stages of steatosis and liver stiffness.
Open AccessOperational merit of Controlled Attenuation Parameter and Liver Stiffness Measurement across grades of Metabolic Dysfunctional Associated Steatotic Liver Disease: A cross-sectional study
Aim and objectives: Metabolic dysfunction-associated steatotic liver disease (MASLD) contributes significantly to global NCD mortality. Often asymptomatic until advanced; early diagnosis prevents worsening. Given the limitations of liver biopsy, non-invasive tests (NITs) like Controlled Attenuation Parameter(CAP) and Liver Stiffness Measurement(LSM) offer promising alternatives. The present study aimed to correlate CAP with LSM and assess CAP and LSM accuracy for stratifying early steatosis and fibrosis using vibration-controlled transient elastography (VCTE). Methods: The SmartExam ® equipment was used in patients at risk for or diagnosed with MASLD. This cross-sectional, prospective, tertiary care hospital-based study included 128 adult patients undergoing ultrasonography and/ or fibro-scan. Results: Participants with steatosis grades 0-3 showed a significant increase in CAP and LSM with disease grades. A strong positive correlation existed between CAP and LSM (r=0.785, p<0.001), highlighting the interdependence of steatosis and liver stiffness. CAP demonstrated excellent diagnostic accuracy for hepatic steatosis (AUROC 1.000, p<0.001), showing substantial increases with steatosis progression. The sensitivity and specificity among individuals with high BMI/WHR were found to be 90.63% and 100% respectively, with a diagnostic accuracy of 97.66%. LSM showed marked elevation for advanced fibrosis, and the performance characteristics were found to be 81.25% sensitive, 82.29% specific, with a diagnostic accuracy of 82.03% in the higher BMI/WHR groups. Conclusion: Our study confirms CAP’s excellent performance in diagnosing and stratifying hepatic steatosis and LSM’s potential role in assessing fibrosis, including early stages of MASLD. The strong CAP-LSM correlation promises synergistic utility across all stages of steatosis and liver stiffness.
- Open Access
- 17 April 2025
- Published by Wiley in Chronic Diseases and Translational Medicine
- Vol. 11 (2) , 89-104
Contemporary Perspectives on Chronic Renal Disorders
The prevalence of renal diseases and its associated burden on healthcare have tremendously risen in the past few years. From simple markers assessing kidney function, current renal research delves into understanding the diseases at the cellular and molecular levels and not just at treating, but at improving quality of life, arresting progression and providing personalized diagnostics and therapy. This narrative review highlights the improvements in diagnostic applications of kidney disease and briefly discusses a few notable biomarkers emphasizing the high throughput omics technologies, as well as contemporary perspectives on renal research. A thorough literature search was performed on PubMed, Scopus, Web of Science, and Medline. Suitable Mesh terms were included for the search strategy, and relevant evidence was documented. Language models and pharmacognosy, along with other omics strategies, impose a better understanding of the renal disease, and the remarkable discoveries of noninvasive biomarkers, urine 273‐peptide classifier, and urine peptides‐based fibrosis classifier have unraveled the associations between mechanistic studies and novel therapeutic drugs. Strides in biomarker research have been able to delineate stages and types with superior specificity and sensitivity, thereby providing a better diagnosis. Renal research reflects a powerful, dynamic, and multifaceted field that drives better advancements and discoveries in personalized medicine, drug interventions, and patient‐centered outcomes. Understanding the tangled relationship of the etiology of kidney disease, these developments and future research hold promise for individuals affected by kidney diseases
- 17 April 2025
- Published by Wiley in Chronic Diseases and Translational Medicine
- Vol. 11 (2) , 89-104
Open AccessContemporary Perspectives on Chronic Renal Disorders
The prevalence of renal diseases and its associated burden on healthcare have tremendously risen in the past few years. From simple markers assessing kidney function, current renal research delves into understanding the diseases at the cellular and molecular levels and not just at treating, but at improving quality of life, arresting progression and providing personalized diagnostics and therapy. This narrative review highlights the improvements in diagnostic applications of kidney disease and briefly discusses a few notable biomarkers emphasizing the high throughput omics technologies, as well as contemporary perspectives on renal research. A thorough literature search was performed on PubMed, Scopus, Web of Science, and Medline. Suitable Mesh terms were included for the search strategy, and relevant evidence was documented. Language models and pharmacognosy, along with other omics strategies, impose a better understanding of the renal disease, and the remarkable discoveries of noninvasive biomarkers, urine 273‐peptide classifier, and urine peptides‐based fibrosis classifier have unraveled the associations between mechanistic studies and novel therapeutic drugs. Strides in biomarker research have been able to delineate stages and types with superior specificity and sensitivity, thereby providing a better diagnosis. Renal research reflects a powerful, dynamic, and multifaceted field that drives better advancements and discoveries in personalized medicine, drug interventions, and patient‐centered outcomes. Understanding the tangled relationship of the etiology of kidney disease, these developments and future research hold promise for individuals affected by kidney diseases
- Open Access
- 1 March 2025
- Published by Science Publications in OnLine Journal of Biological Sciences
- Vol. 25 (3) , 590-600
From Health to Disease: Functional Insights of Scavenger Receptor Class B Type I in Lipid Metabolism and Disease Pathogenesis
Scavenger receptor class B type I (SR-B1) has caught considerable interest among the scientific community due to its pivotal role in several biological and pathological processes. It is a multifunctional integral membrane protein and multiligand receptor encoded by the SCARB1 gene. SR-B1 has a wide distribution, primarily in the liver as well as steroidogenic organs including the gonads and adrenal glands, and a reduced expression is noted in macrophages, adipocytes, lung tissue and endothelial cells. Its expression across different tissues reflects its diversity in various physiological processes. Alongside, defects can alter the normal rhythm of the body's functioning, leading to the pathogenesis of various diseases. In cholesterol-demanding cells, SR-B1 highlights its significant role in cholesterol homeostasis. This paper explores the multifaced role of SR-B1 in regulating cholesterol handling, its involvement in inflammatory signaling pathways, and its interactions with various transcription factors, inflammatory mediators, and as a therapeutic target across various disease contexts.
- 1 March 2025
- Published by Science Publications in OnLine Journal of Biological Sciences
- Vol. 25 (3) , 590-600
Open AccessFrom Health to Disease: Functional Insights of Scavenger Receptor Class B Type I in Lipid Metabolism and Disease Pathogenesis
Scavenger receptor class B type I (SR-B1) has caught considerable interest among the scientific community due to its pivotal role in several biological and pathological processes. It is a multifunctional integral membrane protein and multiligand receptor encoded by the SCARB1 gene. SR-B1 has a wide distribution, primarily in the liver as well as steroidogenic organs including the gonads and adrenal glands, and a reduced expression is noted in macrophages, adipocytes, lung tissue and endothelial cells. Its expression across different tissues reflects its diversity in various physiological processes. Alongside, defects can alter the normal rhythm of the body's functioning, leading to the pathogenesis of various diseases. In cholesterol-demanding cells, SR-B1 highlights its significant role in cholesterol homeostasis. This paper explores the multifaced role of SR-B1 in regulating cholesterol handling, its involvement in inflammatory signaling pathways, and its interactions with various transcription factors, inflammatory mediators, and as a therapeutic target across various disease contexts.
- Open Access
- 24 August 2024
- Published by Veterinary World in Veterinary World
- Vol. 17 (8) , 1855-1863
Evaluation of the cognitive, physiological, and biomarker effects of heavy metal exposure in Wistar rats
Background and Aim: Individuals exposed to heavy metals are known to experience physiological and biochemical changes, which raise questions regarding possible health effects. In our earlier research, significant concentrations of vanadium (V), mercury (Hg), cadmium (Cd), and arsenic (As) were found in food and medical packaging materials. This study aimed to evaluate the cognitive, physiological, and biomarker effects of select heavy metal exposure in Wistar rats. Materials and Methods: Over a 13-week period, five groups of rats (six rats per group, with both males and females) were assessed to study the effects of oral exposure to V, Hg, Cd, and As. The study focused on evaluating physiological, cognitive, and biochemical markers, with the results compared to those of a control group. Results: Comparing all groups of rats treated with heavy metals, the study revealed significant deficits in learning and spatial orientation (water maze test); rats treated with V, Cd, and Hg showed signs of depression. Rats treated with As also showed signs of hyperactivity, which may indicate a connection to attention-deficit hyperactivity disorder (rat tail suspension test). The groups exposed to different heavy metals varied in their physiological (water and food intake, urine and feces output) and biochemical responses (enzyme-linked immunosorbent assay, prostate-specific antigen, T3, T4, thyroid-stimulating hormone, carcinoembryonic antigen, and blood glucose analysis), with Hg exhibiting the strongest impacts. Rats given Hg showed signs of hypothyroidism, such as increased food intake and weight gain. Conclusion: This study clarifies the complex relationships between exposure to heavy metals and various biological systems, shedding light on their potential health impacts. The findings provide insight into the effects of heavy metals on neural and thyroid tissues, as well as their propensity to cause cellular dedifferentiation. However, the study has certain limitations, such as the relatively short duration of exposure and the use of only a few selected biomarkers. Future research should focus on long-term exposure studies, incorporate a broader range of biomarkers, and explore the underlying mechanisms at a molecular level to better understand the full spectrum of health risks associated with heavy metal exposure. Keywords: arsenic, mercury, vanadium, Wistar rats.
- 24 August 2024
- Published by Veterinary World in Veterinary World
- Vol. 17 (8) , 1855-1863
Open AccessEvaluation of the cognitive, physiological, and biomarker effects of heavy metal exposure in Wistar rats
Background and Aim: Individuals exposed to heavy metals are known to experience physiological and biochemical changes, which raise questions regarding possible health effects. In our earlier research, significant concentrations of vanadium (V), mercury (Hg), cadmium (Cd), and arsenic (As) were found in food and medical packaging materials. This study aimed to evaluate the cognitive, physiological, and biomarker effects of select heavy metal exposure in Wistar rats. Materials and Methods: Over a 13-week period, five groups of rats (six rats per group, with both males and females) were assessed to study the effects of oral exposure to V, Hg, Cd, and As. The study focused on evaluating physiological, cognitive, and biochemical markers, with the results compared to those of a control group. Results: Comparing all groups of rats treated with heavy metals, the study revealed significant deficits in learning and spatial orientation (water maze test); rats treated with V, Cd, and Hg showed signs of depression. Rats treated with As also showed signs of hyperactivity, which may indicate a connection to attention-deficit hyperactivity disorder (rat tail suspension test). The groups exposed to different heavy metals varied in their physiological (water and food intake, urine and feces output) and biochemical responses (enzyme-linked immunosorbent assay, prostate-specific antigen, T3, T4, thyroid-stimulating hormone, carcinoembryonic antigen, and blood glucose analysis), with Hg exhibiting the strongest impacts. Rats given Hg showed signs of hypothyroidism, such as increased food intake and weight gain. Conclusion: This study clarifies the complex relationships between exposure to heavy metals and various biological systems, shedding light on their potential health impacts. The findings provide insight into the effects of heavy metals on neural and thyroid tissues, as well as their propensity to cause cellular dedifferentiation. However, the study has certain limitations, such as the relatively short duration of exposure and the use of only a few selected biomarkers. Future research should focus on long-term exposure studies, incorporate a broader range of biomarkers, and explore the underlying mechanisms at a molecular level to better understand the full spectrum of health risks associated with heavy metal exposure. Keywords: arsenic, mercury, vanadium, Wistar rats.
- Open Access
- 21 November 2023
- Published by Hindawi Limited in International Journal of Food Science
- Vol. 2023, 1-8
Evaluation of Minimum Inhibitory Concentration of Heavy Metals Contained in Packaging Material Digest on Prominent Gut Microbiota
Several scientific investigations have revealed that the leaching of metals from packaging material into the packed food is an unavoidable process. Hence, this study is aimed at investigating the effect of leached heavy metals from food packing materials on normal human gut flora. We analysed the effect of vanadium, arsenic, cadmium, and mercury present in digested packaging materials (DPM) on standard strains of Escherichia coli ATCC 25923, Pseudomonas aeruginosa ATCC 27853, Klebsiella pneumoniae ATCC 70063, and Enterococcus faecalis ATCC 29212. The minimum inhibitory concentration (MIC) of laboratory-grade heavy metal salts and heavy metals present in DPM was determined by the agar dilution method. For all four bacteria, the MIC of cadmium and arsenic in the DPM was 7μg/ml and 1.6μg/ml, respectively. The MIC of mercury in DPM was 1.6μg/ml for E. coli, K. pneumoniae, and E. faecalis and 1.4μg/ml for P. aeruginosa. MIC of vanadium for E. coli, P. aeruginosa, and E. faecalis was 2.2μg/ml, and for K. pneumoniae was 2.0μg/ml. The difference in MICs of heavy metals in DPMs and heavy metal salts was not statistically significant. MICs were within CODEX-specified permissible levels. Though heavy metals in packaging material have not shown a deleterious effect on representative human gut flora, there is scope to study their effect on the gut microbiome. Thus, understanding the risk of heavy metal ingestion through unknown sources and avoiding any possible ingestion is crucial to preventing chronic diseases.
- 21 November 2023
- Published by Hindawi Limited in International Journal of Food Science
- Vol. 2023, 1-8
Open AccessEvaluation of Minimum Inhibitory Concentration of Heavy Metals Contained in Packaging Material Digest on Prominent Gut Microbiota
Several scientific investigations have revealed that the leaching of metals from packaging material into the packed food is an unavoidable process. Hence, this study is aimed at investigating the effect of leached heavy metals from food packing materials on normal human gut flora. We analysed the effect of vanadium, arsenic, cadmium, and mercury present in digested packaging materials (DPM) on standard strains of Escherichia coli ATCC 25923, Pseudomonas aeruginosa ATCC 27853, Klebsiella pneumoniae ATCC 70063, and Enterococcus faecalis ATCC 29212. The minimum inhibitory concentration (MIC) of laboratory-grade heavy metal salts and heavy metals present in DPM was determined by the agar dilution method. For all four bacteria, the MIC of cadmium and arsenic in the DPM was 7μg/ml and 1.6μg/ml, respectively. The MIC of mercury in DPM was 1.6μg/ml for E. coli, K. pneumoniae, and E. faecalis and 1.4μg/ml for P. aeruginosa. MIC of vanadium for E. coli, P. aeruginosa, and E. faecalis was 2.2μg/ml, and for K. pneumoniae was 2.0μg/ml. The difference in MICs of heavy metals in DPMs and heavy metal salts was not statistically significant. MICs were within CODEX-specified permissible levels. Though heavy metals in packaging material have not shown a deleterious effect on representative human gut flora, there is scope to study their effect on the gut microbiome. Thus, understanding the risk of heavy metal ingestion through unknown sources and avoiding any possible ingestion is crucial to preventing chronic diseases.
- Open Access
- 17 November 2023
- Published by Taylor & Francis in CyTA - Journal of Food
- Vol. 21 (1) , 711-717
Assessing the impact of heavy metal residues in food and drug packaging on the standard bacterial strains: a biofilm perspective
- 17 November 2023
- Published by Taylor & Francis in CyTA - Journal of Food
- Vol. 21 (1) , 711-717
Open AccessAssessing the impact of heavy metal residues in food and drug packaging on the standard bacterial strains: a biofilm perspective
- Open Access
- 31 August 2023
- Published by Enviro Research Publishers in Current Research in Nutrition and Food Science Journal
- Vol. 11 (2) , 822-829
Pre-Post Assessment of Serum Zinc and Copper Status in Uncomplicated Pulmonary Tuberculosis Patients Receiving Directly Observed Treatment Short Course
Mycobacterium tuberculosis causing the infectious disease tuberculosis has a predilection for the lungs although it is common to see other organs involved. India has adopted the TB-DOTS program for the treatment of the same. Undernutrition and tuberculosis are mutually inclusive. Micronutrients like zinc and copper play a key role in cytokine kinetics and immunity and thus are important in an individual's response to infectious disease. Serum copper and zinc levels in patients with pulmonary tuberculosis (pTB) before and after two months of directly observed treatment short course (DOTS) were assessed in this study. The serum samples of 39 pTB patients were collected before the commencement of anti-tubercular therapy (ATT) and tested for copper and zinc levels. At the end of the intensive phase of treatment, blood samples of 31 out of the 39 pTB patients were again collected and tested for the same trace elements. In the pre-post comparison of 31 patients who could be followed up, an increase in serum zinc levels [101 (74.9) μg/ dl vs 112(155.5) μg/dl)] after the treatment was not statistically significant (p=0.15). The serum copper levels [184(105.7) μg/dl vs 247(80.8) μg/dl)] were significantly (p<0.01) increased after two months of DOTS therapy. Sputum negativity was close to 81%.Serum copper, as well as zinc levels, were increased after DOTS therapy for two months. Since the response to therapy was 69%, supplementation of copper and zinc may benefit the pTB patients in achieving sputum negativity sooner and completely.
- 31 August 2023
- Published by Enviro Research Publishers in Current Research in Nutrition and Food Science Journal
- Vol. 11 (2) , 822-829
Open AccessPre-Post Assessment of Serum Zinc and Copper Status in Uncomplicated Pulmonary Tuberculosis Patients Receiving Directly Observed Treatment Short Course
Mycobacterium tuberculosis causing the infectious disease tuberculosis has a predilection for the lungs although it is common to see other organs involved. India has adopted the TB-DOTS program for the treatment of the same. Undernutrition and tuberculosis are mutually inclusive. Micronutrients like zinc and copper play a key role in cytokine kinetics and immunity and thus are important in an individual's response to infectious disease. Serum copper and zinc levels in patients with pulmonary tuberculosis (pTB) before and after two months of directly observed treatment short course (DOTS) were assessed in this study. The serum samples of 39 pTB patients were collected before the commencement of anti-tubercular therapy (ATT) and tested for copper and zinc levels. At the end of the intensive phase of treatment, blood samples of 31 out of the 39 pTB patients were again collected and tested for the same trace elements. In the pre-post comparison of 31 patients who could be followed up, an increase in serum zinc levels [101 (74.9) μg/ dl vs 112(155.5) μg/dl)] after the treatment was not statistically significant (p=0.15). The serum copper levels [184(105.7) μg/dl vs 247(80.8) μg/dl)] were significantly (p<0.01) increased after two months of DOTS therapy. Sputum negativity was close to 81%.Serum copper, as well as zinc levels, were increased after DOTS therapy for two months. Since the response to therapy was 69%, supplementation of copper and zinc may benefit the pTB patients in achieving sputum negativity sooner and completely.
- 28 February 2023
- Published by A and V Publications in Research Journal of Pharmacy and Technology
- Vol. 16 (2) , 879-884
Delayed Structure – function alterations in Pancreas and Liver of Rodent Diabetic Model treated with Salacia oblonga.
Salacia oblonga (S. oblonga) is a component of several antidiabetic medications in alternative and folklore medicine. An evaluation of the hydroalcoholic root extract of S.oblonga (SOE) on the hepatocellular and pancreatic environment in the diabetic (Streptozotocin) rodent model was designed. SOE was fed in two doses for a period of 16 weeks. Regeneration of endocrine pancreas, significant increase in hepatic and pancreatic Vitamin C, reduced Glutathione (GSH), Protein thiols (PT) and decrease in Malondialdehyde (MDA measured as TBARS) and Carbonyl proteins (CP) were observed on treatment with SOE. Conversely, there was also an increase in alkaline phosphatase (ALP) and gamma glutamyl transferase (GGT). Corroborating the above findings, histopathological examination of the liver and pancreatic tissue showed disrupted architecture in treated rats. It may be suggested that SOE has a sustained hepatic antioxidant effect and improved β-cell structure and function in diabetic rats, but the higher dose was mildly toxic to hepatocytes necessitating an exercise of caution in using SOE for therapy for prolonged periods.
- 28 February 2023
- Published by A and V Publications in Research Journal of Pharmacy and Technology
- Vol. 16 (2) , 879-884
Delayed Structure – function alterations in Pancreas and Liver of Rodent Diabetic Model treated with Salacia oblonga.
Salacia oblonga (S. oblonga) is a component of several antidiabetic medications in alternative and folklore medicine. An evaluation of the hydroalcoholic root extract of S.oblonga (SOE) on the hepatocellular and pancreatic environment in the diabetic (Streptozotocin) rodent model was designed. SOE was fed in two doses for a period of 16 weeks. Regeneration of endocrine pancreas, significant increase in hepatic and pancreatic Vitamin C, reduced Glutathione (GSH), Protein thiols (PT) and decrease in Malondialdehyde (MDA measured as TBARS) and Carbonyl proteins (CP) were observed on treatment with SOE. Conversely, there was also an increase in alkaline phosphatase (ALP) and gamma glutamyl transferase (GGT). Corroborating the above findings, histopathological examination of the liver and pancreatic tissue showed disrupted architecture in treated rats. It may be suggested that SOE has a sustained hepatic antioxidant effect and improved β-cell structure and function in diabetic rats, but the higher dose was mildly toxic to hepatocytes necessitating an exercise of caution in using SOE for therapy for prolonged periods.